Article

Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text
Advertising


Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

  • You can purchase this item in Pay Per ViewPay per View - FAQ : 30,00 € Taxes included to order
    Pages Iconography Videos Other
    3 0 0 0


Revue du rhumatisme
Volume 68, n° 1
pages 7-9 (janvier 2001)
Received : 18 October 2000 ;  accepted : 25 October 2000
L'interleukine 10 : une nouvelle cible thérapeutique dans le lupus érythémateux disséminé ?

Dominique  Emilie 1 ,  Xavier  Mariette 2
1Service de médecine interne et d'immunologie clinique, institut Paris-Sud sur les cytokines, hôpital Antoine-Béclère, 157, rue de la Porte-de-Trivaux, 92141 Clamart cedex, France 
2service de rhumatologie, hôpital de Bicêtre, 78, rue du Général-Leclerc, 94275 le Kremlin-Bicêtre cedex, France 

Correspondance et tirés à part

Mots clés  : biothérapie ; interleukine 10 ; lupus.

Mots clés  : biotherapy ; interleukin 10 ; lupus.




© 2001  Éditions scientifiques et médicales Elsevier SAS. All Rights Reserved.

EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline
You can move this window by clicking on the headline